Roxithromycin Tablets

It is a new generation of macrolide antibiotics, mainly acting on Gram-positive bacteria, anaerobic bacteria, Chlamydia and Mycoplasma, etc. Its in vitro antibacterial effect is similar to that of erythromycin, and its in vivo antibacterial effect is 1 to 4 times stronger than that of erythromycin.

Roxithromycin

Film-coated tablets appear white after removing the film coating.

1 Suitable for the following infections caused by sensitive strains: (1) upper respiratory tract infections; (2) lower respiratory tract infections; (3) ear, nose and throat infections; (4) genital infections (except gonococcal infections); (5) skin and soft tissue infections. 2 Can also be used for mycoplasma pneumonia, Chlamydia trachomatis infections and Legionnaires' disease.

Oral administration: Adults: 0.15g at a time, twice a day, or as directed by a doctor.

Gastrointestinal reactions, rash, and elevated ALT and AST may be seen.

It is contraindicated for those who are allergic to this product. It is contraindicated to be used in combination with ergotamine and dihydroergotamine.

Precautions for children: Not clear. Precautions for pregnancy and lactation: Use with caution in pregnant and lactating women. A dosage of less than 0.05% is excreted into breast milk. Although there are reports that it has little effect on infants, it is still necessary to consider whether to stop breastfeeding. Precautions for the elderly: If there is no significant change in pharmacokinetics in the elderly, there is no need to adjust the dose.

Not yet clear

Sealed, stored in a dry place

150mg (150,000 units)

24 months

Yiling Pharmaceutical Ltd.

• Founded in:

  2014-07-28

• Address:

  No. 36, Zhujiang Avenue, Shijiazhuang High-tech Zone

• Tax NO.:

  911301013989550179

• Registered Funds:

  675 million yuan

• Website:

  Log in to view

• Email:

  Log in to view